stars 1 stars 2 stars 3

The MFAbs basically includes Polyclonal Antibodies (pAb), Monoclonal Antibodies (mAb) and Recombinant Antibodies (rAb) and Antibody Engineering Fragments (Ab-Eng). Our MFAbs technologies incorporate traditional and proprietary serological and genetic engineering approaches to produce antibodies formatted to exhibit defined antigen binding specificities and immunological properties. Offering MFAb development solutions from research through commercialization, ABBIOSCI is a provider of the following product and service lines: Format of antibodies (pAb, mAb, rAb) productions mAb to rAb antibody rescue or conversion Antibody class (e.g. IgM to IgG) and subclass (IgG1, 2a, 2b, 3 or 4) switch rAb conversion to a full IgG or chimeric antibody rAb (chicken, human, monkey, mouse, rabbit, rat) library construction and selection Antibody genes and analysis as well as Gene-based antibody generation Bi-specific antibody (Bis-Ab) construction Antibody characterization and epitope mapping Immunoassay development Antibody affinity maturation Antibody post-translational (e.g. glycosylation) modification Home | About AbBioSci | Antibody Formats | Antibody Pools | Antigen Pools | Products | Services | Support Copyright © 2017 AbBioSci, Inc.

AbBioSci Questions

The AbBioSci annual revenue was $6 million in 2026.

AbBioSci is based in Seattle, Washington.

The NAICS codes for AbBioSci are [5417, 54, 541713, 54171, 541].

The SIC codes for AbBioSci are [873, 87].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users